Evonik sells Hanau-based production assets for pharmaceutical ingredients to ProChem
Evonik is selling selected production assets for pharmaceutical ingredients in Hanau, Germany to the contract manufacturer ProChem Group. The transaction, which is expected to close on June 19, 2026, supports the growth strategy of Evonik’s Health Care business.